Virios Therapeutics, Inc.
VIRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,563 | $270 | $65 | $1,065 |
| - Cash | $0 | $3 | $7 | $14 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4,563 | $267 | $58 | $1,051 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,227 | $0 | -$12 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$12,864 | -$5 | -$12 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.52 | -0.28 | -1.1 | -1.92 |
| % Growth | -4,371.4% | 74.5% | 42.7% | – |
| Operating Cash Flow | -$8,791 | -$5 | -$11 | -$16 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8,791 | -$5 | -$11 | -$16 |